Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.24 HKD | -3.12% | -13.29% | -45.61% |
May. 15 | Brii Bio's Hepatitis B Drugs Get Breakthrough Therapy Designation in China | MT |
Mar. 25 | Transcript : Brii Biosciences Limited, 2023 Earnings Call, Mar 25, 2024 |
Sales 2024 * | - | Sales 2025 * | 181M 24.94M 195M | Capitalization | 867M 120M 934M |
---|---|---|---|---|---|
Net income 2024 * | -528M -72.89M -569M | Net income 2025 * | -412M -56.87M -444M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 4.8 x |
P/E ratio 2024 * |
-1.83
x | P/E ratio 2025 * |
-3.39
x | Employees | 128 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.51% |
Latest transcript on Brii Biosciences Limited
1 day | -3.13% | ||
1 week | -13.29% | ||
Current month | -0.80% | ||
3 months | -32.24% | ||
6 months | -59.74% | ||
Current year | -45.61% |
Managers | Title | Age | Since |
---|---|---|---|
Zhi Hong
CEO | Chief Executive Officer | 60 | 17-12-07 |
An Kang Li
DFI | Director of Finance/CFO | 47 | 20-08-31 |
David Margolis
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregg Alton
BRD | Director/Board Member | 58 | 21-06-21 |
Tai Yin Yang
BRD | Director/Board Member | 70 | 22-08-31 |
Robert Nelsen
BRD | Director/Board Member | 60 | 18-06-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.53% | 4 M€ | -27.92% | ||
0.00% | 4 M€ | -4.41% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-27 | 1.24 | -3.12% | 64 500 |
24-05-27 | 1.28 | +0.79% | 767,000 |
24-05-24 | 1.27 | -2.31% | 1,130,000 |
24-05-23 | 1.3 | -5.11% | 2,246,500 |
24-05-22 | 1.37 | +1.48% | 1,089,500 |
Delayed Quote Hong Kong S.E., May 27, 2024 at 10:54 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.61% | 119M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-0.29% | 21.78B | |
-9.28% | 18.09B | |
-41.70% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- 2137 Stock